AcelRx Pharmaceuticals, Inc.
USD0.86
+0.06 (+7.50%)
CEO
Vincent J. Angotti
IPO Date
2011-02-11
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.78
Prev. Close
$0.80
Day Low
$0.78
Day High
$0.88
52W Low
$0.42
52W High
$2.30
Market Cap
$0.01B
Volume
0.24M
| -1.0 |
| 31 Dec 2023 | FY | -751.9% | -2826.0% | -130.4% | -90.2% | 0.00 | 2.56 | -0.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 194.9% | 89.5% | 0.46 | 1.78 | 0.4 |
| 31 Dec 2021 | FY | -695.2% | -9285.4% | 97.8% | -45.1% | -0.52 | 2.73 | -1.9 |
| 31 Dec 2020 | FY | -11.4% | -745.6% | 72.4% | -60.9% | -0.46 | 2.66 | -2.6 |
| 31 Dec 2019 | FY | -197.3% | -2325.9% | 128.5% | -58.3% | -2.94 | 5.27 | -3.1 |
| 31 Dec 2018 | FY | -84.8% | -2192.0% | -1108.6% | -39.1% | 24.85 | 6.78 | -2.9 |
| 31 Dec 2017 | FY | -33.3% | -644.3% | 141.1% | -68.2% | -2.81 | 4.64 | -1.9 |
| 31 Dec 2016 | FY | 29.0% | -248.6% | 808.6% | -43.2% | -17.71 | 8.74 | -2.7 |
| -3.2 |
| 30 Sept 2025 | Q3 | 100.0% | -443600.0% | -23.1% | -14.4% | 0.34 | 6.83 | -2.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -52.6% | -21.1% | 0.00 | 2.93 | -1.1 |
| 31 Mar 2025 | Q1 | -4229.6% | -9603.7% | -46.3% | -17.3% | 0.00 | 3.11 | -1.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -23.4% | -10.3% | 0.82 | 3.56 | -1.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -34.8% | -16.0% | 0.68 | 4.42 | -1.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -30.1% | -15.4% | 0.51 | 4.90 | -1.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -24.2% | -13.7% | 0.39 | 5.97 | -1.7 |
| 31 Dec 2023 | Q4 | -529.5% | -1607.5% | -32.0% | -22.1% | 0.00 | 2.56 | -0.8 |